Robert Kester is a Senior Director, Global Regulatory Liaison Oncology at Merck & Co. Inc. He has been at Merck for more than eight years and began as a Regulatory Liaison focused on developing Rest of World regulatory strategies before transitioning to his current role in 2016 supporting the global development strategy of oncology products. In his current role, he is a Global Regulatory Team Lead for the lung cancer program and led one of the first RTOR submissions to the US FDA. During his time at Merck, he has also served as a Chief of Staff and has provided regulatory intelligence support to the group. Prior to joining Merck, Robert obtained his MA from Harvard University and worked at Roche for 15 years as a Discovery Chemist.